Marylène Guerlais
- Toxicology top 5%
- Forensic Toxicology and Drug Analysis 9
- Geriatrics and Gerontology top 10%
-
- Sleep and related disorders 5
-
- Schizophrenia research and treatment 6
-
- Opioid Use Disorder Treatment 9
-
- Substance Abuse Treatment and Outcomes 5
- HIV, Drug Use, Sexual Risk 4
-
- Alcoholism and Thiamine Deficiency 4
-
- Treatment of Major Depression 4
- Co-authors
- Caroline Victorri‐VigneauMarie Grall‐BronnecPascale JollietMarie GérardinEdouard‐Jules LaforgueMorgane RousseletFanny FeuilletAmélie Daveluy
- Journals
- Expert Opinion on Drug Safety (2 papers)Substance Use & Misuse (2 papers)British Journal of Clinical Pharmacology (2 papers)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Marylène Guerlais
30 papers receiving 262 citations
Peers
Comparison fields: 5 of 65
- Toxicology 65
- Geriatrics and Gerontology 32
- Experimental and Cognitive Psychology 56
- Psychiatry and Mental health 45
- Family Practice 6
Countries citing papers authored by Marylène Guerlais
This map shows the geographic impact of Marylène Guerlais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marylène Guerlais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marylène Guerlais more than expected).
Fields of papers citing papers by Marylène Guerlais
This network shows the impact of papers produced by Marylène Guerlais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marylène Guerlais. The network helps show where Marylène Guerlais may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marylène Guerlais, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 12 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 0 | |
| 10 | 2020 | 28 | |
| 11 | 2020 | 18 | |
| 12 | 2020 | 6 | |
| 13 | 2020 | 11 | |
| 14 | 2019 | 14 | |
| 15 | 2018 | 1 | |
| 16 | 2017 | 36 | |
| 17 | 2016 | 9 | |
| 18 | 2016 | 2 | |
| 19 | 2014 | 49 | |
| 20 | 2014 | 20 |
About Marylène Guerlais
Marylène Guerlais is a scholar working on Toxicology, Psychiatry and Mental health and Geriatrics and Gerontology, having authored 36 papers that have together received 269 indexed citations. Recurring topics across this work include Opioid Use Disorder Treatment (9 papers), Forensic Toxicology and Drug Analysis (9 papers), Schizophrenia research and treatment (6 papers), Sleep and related disorders (5 papers), Substance Abuse Treatment and Outcomes (5 papers), Alcoholism and Thiamine Deficiency (4 papers), HIV, Drug Use, Sexual Risk (4 papers) and Treatment of Major Depression (4 papers). The work is most often cited by research in Toxicology (65 citations), Geriatrics and Gerontology (32 citations) and Experimental and Cognitive Psychology (56 citations). Marylène Guerlais has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Caroline Victorri‐Vigneau, Marie Grall‐Bronnec, Pascale Jolliet, Marie Gérardin, Edouard‐Jules Laforgue, Morgane Rousselet, Fanny Feuillet, Amélie Daveluy, Élisabeth Frauger and Valérie Gibaja. Their work appears in journals such as Expert Opinion on Drug Safety, Substance Use & Misuse, British Journal of Clinical Pharmacology, PLoS ONE and Therapies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.